Both in Medical Labs
Aclarion vs Sera Prognostics
Over the past year ACON returned −73.5% and SERA returned −45.9%; their daily moves had a correlation of 0.09.
ACON −73.5% SERA −45.9%Growth of $1, one year, split-adjusted
| Metric | ACON | SERA |
|---|---|---|
| Price | $2.04 | $2.03 |
| Market cap | $5.9M | $80.1M |
| Today | +6.25% | −0.98% |
| 1 month | −14.3% | +1.0% |
| 6 months | −37.4% | +2.0% |
| Year to date | −55.7% | −31.2% |
| 1 year | −73.3% | −45.7% |
| Revenue growth (YoY) | +30.5% | +76.5% |
| Gross margin | 32.9% | −66.7% |
| Net margin | −10899.5% | −30463.3% |
| P/E (TTM) | — | — |
| Price / sales | 70.2× | 1,144.0× |
| Net cash | $16.3M | $46.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 34.0% |
| Short % of float | 0.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).